Dr. Rhonda Patrick Tells Joe Rogan the Risk of Adverse Reactions to the Covid Vaccine Are Relatively Low
Dr. Rhonda Patrick explains why the risk of vaccine side-effects is relatively low and warns about the dangers of vaccine misinformation on Joe Rogan's podcast.
Unvaccinated 60 times more likely to end up in ICU with COVID-19, Ontario data shows
Three charts released by the Ontario COVID-19 Science Advisory Table demonstrate the vast difference between vaccinated and unvaccinated people when it comes to COVID-19 risks.
Comedian Russell Brand Has Become a Powerful Voice for Anti-Vaxxers
The comedian seems to have found a loyal fan base in conservatives and anti-vaxxers who have flocked to his YouTube and Facebook accounts for his rambling vaccine-skeptic views.
The impact of SARS-CoV-2 vaccination on Alpha & Delta variant transmission
Background Pre-Delta, vaccination reduced SARS-CoV-2 transmission from individuals infected despite vaccination, potentially via reducing viral loads. While vaccination still lowers the risk of infection, similar viral loads in vaccinated and unvaccinated individuals infected with Delta question how much vaccination prevents transmission.
Methods We performed a retrospective observational cohort study of adult contacts of SARS-CoV-2-infected adult index cases using English contact testing data. We used multivariable Poisson regression to investigate associations between transmission and index case and contact vaccination, and how these vary with Alpha and Delta variants (classified using S-gene detection/calendar trends) and time since second vaccination.
Results 54,667/146,243(37.4%) PCR-tested contacts of 108,498 index cases were PCR-positive. Two doses of BNT162b2 or ChAdOx1 vaccines in Alpha index cases were independently associated with reduced PCR-positivity in contacts (aRR, adjusted rate ratio vs. unvaccinated=0.32[95%CI 0.21-0.48] and 0.48[0.30-0.78] respectively). The Delta variant attenuated vaccine-associated reductions in transmission: two BNT162b2 doses reduced Delta transmission (aRR=0.50[0.39-0.65]), more than ChAdOx1 (aRR=0.76[0.70-0.82]). Variation in Ct values (indicative of viral load) explained 7-23% of vaccine-associated transmission reductions. Transmission reductions declined over time post-second vaccination, for Delta reaching similar levels to unvaccinated individuals by 12 weeks for ChAdOx1 and attenuating substantially for BNT162b2. Protection in contacts also declined in the 3 months post-second vaccination.
Conclusions Vaccination reduces transmission of Delta, but by less than the Alpha variant. The impact of vaccination decreased over time. Factors other than PCR Ct values at diagnosis are important in understanding vaccine-associated transmission reductions. Booster vaccinations may help control transmission together with preventing infections.
### Competing Interest Statement
DWE declares lecture fees from Gilead outside the submitted work. No other author has a conflict of interest to declare.
### Funding Statement
This study was funded by the UK Government's Department of Health and Social Care. This work was supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at Oxford University in partnership with Public Health England (PHE) (NIHR200915), and the NIHR Biomedical Research Centre, Oxford. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health or Public Health England. DWE is a Robertson Foundation Fellow and an NIHR Oxford BRC Senior Fellow. ASW is an NIHR Senior Investigator.
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was performed as public health surveillance and NHS Test and Trace program quality assurance, under Section 251 of the NHS Act 2006 with approvals from Public Health England (PHE), the Department of Health and Social Care and NHS Test and Trace. PHE's Research Ethics and Governance Group (PHE's Research Ethics Committee) reviewed the study protocol and confirmed compliance with all regulatory requirements. As no regulatory or ethical issues were identified, it was agreed that full ethical review was not needed, and the protocol was approved.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Applications to use the data in this study can be made to NHS Digital's Data Access Request Service, please see for more details.
‘Rage’: Physicians speak out against threats over COVID-19 public health measures
Both the Canadian and Ontario medical associations believe that intentional bullying directed at physicians and health-care workers is a crime and should be actively prosecuted.
Vaccine reduces transmission in breakthrough cases
Breakthrough COVID-19 cases in vaccinated people may be less likely to spread infection because virus is shed for a shorter period of time as opposed to infections in unvaccinated people.
A lack of testing data and government guidance led many to avoid the COVID-19 vaccine during pregnancy, unwittingly increasing their chances of a stillbirth.
Answers from COVID experts: How do you talk to family members who aren’t vaccinated? How can the vaccines be safe if they were developed so quickly? Is natural immunity better than being vaccinated?
A panel of experts answer questions about vaccines, omicron and other COVID-related issues in a discussion with The Conversation.
Montana COVID Policy Brought a Hospital to the Brink
Montana’s GOP-led COVID response brought waves of patients to a Helena hospital, forcing health care workers to make difficult care decisions for COVID and non-COVID patients alike.
Professor Massimo Hilliard and Dr Ramon Martinez-Marmol have discovered viruses such as SARS-CoV-2 can cause brain cells to fuse, initiating malfunctions that lead to chronic neurological symptoms.
Health Do’s and Don’ts After Covid Vaccination - Elemental
For the most part, getting a Covid-19 vaccination shouldn’t change any of your typical health, fitness, or wellness routines, or at least not for more than a day or two. Still, it’s reasonable to…
Kelly Brogan's Covid-Denying Conspiracy Machine | GEN
Kelly Brogan, Sayer Ji, and the growing influence of the 'conspirituality' movement, a dangerous combination of covid-denialism and vax-resistance that threatens the public health
After a weak early response to COVID, Israel leads the world in vaccinations. The benefits are apparent, Eran Segal says. But hurdles remain, including finishing vaccinations and staving off variants.